
Geneyx is a clinical genetic data analysis platform founded in 2018, providing AI/ML-powered solutions for DNA/RNA sequencing data interpretation including whole genome, exome, and gene panels. The platform integrates multiomics approaches and automates workflows to reduce turnaround times and increase diagnostic accuracy, serving hospitals, genetic labs, and life-science companies globally. Geneyx supports short and long-read sequencing technologies and offers advanced annotation, reporting, and phenotype-driven interpretation, contributing to national genome projects and achieving diagnostic yields over 65%. It has partnerships with Oxford Nanopore, PacBio, Microsoft, AWS, and Accenture, with installations in 190 hospitals and labs across 50 countries and over 520,000 samples analyzed.

Geneyx is a clinical genetic data analysis platform founded in 2018, providing AI/ML-powered solutions for DNA/RNA sequencing data interpretation including whole genome, exome, and gene panels. The platform integrates multiomics approaches and automates workflows to reduce turnaround times and increase diagnostic accuracy, serving hospitals, genetic labs, and life-science companies globally. Geneyx supports short and long-read sequencing technologies and offers advanced annotation, reporting, and phenotype-driven interpretation, contributing to national genome projects and achieving diagnostic yields over 65%. It has partnerships with Oxford Nanopore, PacBio, Microsoft, AWS, and Accenture, with installations in 190 hospitals and labs across 50 countries and over 520,000 samples analyzed.